Pharmaceutical Policy Analysis

Organizing institution
Utrecht University - Faculty of Science
Course code
M07
Course fee (excl. housing)
€ 975.00
Level
Advanced Master
Apply now!

This course will give students insight into current developments in pharmaceutical policy making as well as give a better understanding of the methods available for analysing the effects of policy interventions. As a collaborator on this course, the World Health Organization will provide lecturers for several of the sessions. You will experience an intensive programme covering the following topics: pharmaceutical policy analysis issues and methods; availability and affordability of medicines; universal health coverage; pricing and reimbursement (including the role of health technology assessment); regulatory issues and challenges; policy and politics; synthesis, case studies & public health.

Medicines are among the most regulated products in society. From the earliest pre-clinical stages onward, policy makers want to foster the development of safe, effective and affordable medicines for patients in need of pharmacotherapy. When a drug reaches the market, it is the beginning of a process of complex interactions between patients, prescribers, insurers, pharmaceutical companies and governments. Furthermore, the inequity in access to medicines is still a defining characteristic of the global pharmaceutical market place. The aim of the course is to give students insight into current developments in pharmaceutical policy making as well to give a better understanding of the methods available for analysing the effects of policy interventions.

As a collaborator on this course, the World Health Organization will provide faculty for several of the sessions. You will experience an intensive programme covering the following topics: pharmaceutical policy analysis issues and methods; availability and affordability of medicines; universal health coverage; pricing and reimbursement (including the role of health technology assessment); regulatory issues and challenges; policy and politics; synthesis, case studies & public health.

Course director

Prof. Dr. Aukje Mantel-Teeuwisse

Lecturers

Prof. Dr. Bert Leufkens, Prof. Dr. Aukje Mantel, Dr. Rianne van den Ham, Dr. Helga
Gardarsdottir, Dr. Wim Goettsch and other UU and WHO staff members.

Target audience

(Post)graduates and professionals within governments, NGOs, industry, universities with a basic knowledge of public health/medicine, who have an interest in the policy aspects of pharmaceuticals and/or pharmacoepidemiology.

Course aim

The aim of the course is to give students insight into current developments in pharmaceutical policy making as well to give a better understanding of the methods available for analysing the effects of policy interventions. As a collaborator on this course, the World Health Organization will provide faculty for several of the sessions.

Study load

1 week full time

Costs

Course fee
€ 975.00
Housing fee
€ 200.00

Housing through Utrecht Summer School

One course dinner is included in the course fee. The course can be combined with the course M08 - Pharmacoepidemiology and Drug Safety or Future Medicines to receive a discount. When combined with one of these courses, the discount will be € 200.00 per course.

More information

Dr. Rianne van den Ham | E: h.a.vandenham@uu.nl | T: +31 6 22 73 59 84

Recommended combinations
Pharmacoepidemiology and Drug Safety
Future Medicines: Gene & Cell Therapies

Registration

Application deadline: 01 June 2020